Cost-effectiveness of upcoming treatments for hepatitis C: we need to get the models right.
Sheila Sherlock Liver Unit and UCL Institute of Liver and Digestive Health, Royal Free Hospital, UK. Electronic address: e.tsochatzis@ucl.ac.uk.
Emmanuel A
EA
Tsochatzis
Health Economics Research Group, Brunel University, UK.
Catriona
C
Crossan
Health Economics Research Group, Brunel University, UK.
Louise
L
Longworth
D000998:Antiviral Agents / Q000008:administration & dosage*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans
D000998:Antiviral Agents